Sequelae of Fetal Growth Restriction

Journal of Medical Ultrasound

Volumn 20, Issue 4, 2012, Pages 191-200

  Ismail, Hamizah ^a,b   Chang, Yao Lung ^b,c  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Developmental origin of adult disease; Fetal origin of adult disease; Fetal programming; Intrauterine or fetal growth restriction

Indexed keywords

GROWTH HORMONE; LEPTIN; LONG CHAIN POLYUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; STEROID; UNCLASSIFIED DRUG;

ADIPOCYTE; ATHEROSCLEROSIS; BRAIN PERFUSION; CATCH UP GROWTH; CEREBRAL PALSY; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; EPIGENETICS; EXERCISE; FETUS DISEASE; FETUS GROWTH; FETUS MORTALITY; FETUS OUTCOME; GROWTH DISORDER; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RESTRICTION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUTRITIONAL SUPPORT; OBESITY; PATIENT MONITORING; REVIEW; RISK FACTOR; SMALL FOR DATE INFANT; SURVIVAL; VASCULAR RESISTANCE;

EID: 84871615754     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmu.2012.10.005     Document Type: Review

References (112)

1. Barker D.J., Fall C.H. Fetal and infant origins of cardiovascular disease. Arch Dis Child 1993, 68:797-799.
2. Leonard H., Nassar N., Bourke J., et al. Relation between intrauterine growth and subsequent intellectual disability in a ten-year population cohort of children in western Australia. Am J Epidemiol 2008, 167:103-111.
3. Barker D.J. The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci 2004, 359:1359-1366.
4. Barker D.J., Baqby S.P. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 2005, 16:2537-2544.
5. Kaijser M., Bonamy A.K., Akre O., et al. Perinatal risk factors for ischemic heart disease: disentangling the roles of birth weight and preterm birth. Circulation 2008, 117:405-410.
6. Geva R., Eshel R., Leitner Y., et al. Memory functions of children born with asymmetric intrauterine growth restriction. Brain Res 2006, 1117:186-194.
7. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077-1081.
8. Mastorci F., Vicentini M., Viltart O., et al. Long-term effects of prenatal stress: changes in adult cardiovascular regulation and sensitivity to stress. Neurosci Biobehav Rev 2009, 33:191-203.
9. Desai M., Babu J., Ross M.G. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol 2007, 293:R2306-R2314.
10. Thamotharan M., Garg M., Oak S., et al. Transgenerational inheritance of the insulin-resistant phenotype in embryo-transferred intrauterine growth-restricted adult female rat offspring. Am J Physiol Endocrinol Metab 2007, 292:E1270-E1279.
11. Sibai B.M. Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease?. Hypertension 2008, 51:993-994.
12. Berends A.L., de Groot C.J., Sijbrands E.J., et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008, 51:1034-1041.
13. Agnihotri B., Antonisamy B., Priya G., et al. Trends in human birth weight across two successive generations. Indian J Pediatr 2008, 75:111-117.
14. Drake A.J., Walker B.R. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 2004, 180:1-16.
15. Hall J.G. The importance of the fetal origins of adult disease for geneticists. Clin Genet 2007, 72:67-73.
16. Jansson T., Powell T.L. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 2007, 113:1-13.
17. Fu Q., Yu X., Callaway C.W., et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J 2009, 23:2438-2449.
18. Guo L., Choufani S., Ferreira J., et al. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol 2008, 320:79-91.
19. Raychaudhuri N., Raychaudhuri S., Thamotharan M., et al. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J Biol Chem 2008, 283:13611-13626.
20. Verburg B.O., Jaddoe V.W., Wladimiroff J.W., et al. Fetal hemodynamic adaptive changes related to intrauterine growth: the generation R study. Circulation 2008, 117:649-659.
21. Vuguin P.M. Animal models for small for gestational age and fetal programming of adult disease. Horm Res 2007, 68:113-123.
22. Dulloo A.G. Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 2008, 22:155-171.
23. Singhal A., Cole T.J., Fewtrell M., et al. Promotion of faster weight gain in infants born small for gestational age: is there adverse effect on later blood pressure. Circulation 2007, 115:213-220. http://www.ncbi.nlm.nih.gov/pubmed?term=Kennedy%2520K%255BAuthor%255D&cauthor=true&cauthor_uid=17179023.
24. Leunissen R.W., Kerhof G.F., Stijnen T., et al. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 2009, 301:2234-2242.
25. Lee P.A., Chernausek S.D., Hokken-Koelega A.C., et al. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003, 111:1253-1261.
26. Miller J., Turan S., Baschat A.A. Fetal growth restriction. Semin Perinatol 2008, 32:274-280.
27. Turan S., Miller J., Baschat A.A. Integrated testing and management in fetal growth restriction. Semin Perinatol 2008, 32:194-200.
28. Mari G., Hanif F., Drennan K., et al. Staging of intrauterine growth-restricted fetuses. J Ultrasound Med 2007, 26:1469-1477. quiz 1479.
29. Baschat A.A. Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction. Ultrasound Obstet Gynecol 2004, 23:111-118.
30. Rizzo G., Capponi A., Cavicchioni O., et al. Low cardiac output to the placenta: an early hemodynamic adaptive mechanism in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008, 32:155-159.
31. Pardi G., Cetin I., Marconi A.M., et al. Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med 1993, 328:692-696.
32. Mari G., Picconi J. Doppler vascular changes in intrauterine growth restriction. Semin Perinatol 2008, 32:182-189.
33. Quinton A.E., Cook C.M., Peek M.J. The relationship between cigarette smoking, endothelial function and intrauterine growth restriction in human pregnancy. BJOG 2008, 115:780-784.
34. Kayemba-Kay's S., Geary M.P., Pringle J., et al. Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants. Eur J Endocrinol 2008, 159:217-224.
35. Byers B.D., Betancourt A., Lu F., et al. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am J Obstet Gynecol 2009, 200:432.e1-432.e7.
36. Hendrix N., Berghella V. Non-placental causes of intrauterine growth restriction. Semin Perinatol 2008, 32:161-165.
37. Fernandez-Twinn D.S., Ozanne S.E. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006, 88:234-243.
38. de Vrijer B., Regnault T.R., Wilkening R.B., et al. Placental uptake and transport of ACP, a neutral nonmetabolizable amino acid, in an ovine model of fetal growth restriction. Am J Physiol Endocrinol Metab 2004, 287:E1114-E1124.
39. Bubb K.J., Cock M.L., Black M.J., et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J Physiol 2007, 578:871-881.
40. Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol 2006, 38:873-893.
41. Pascoe K.C., Wlodek M.E., Jones G.T. Increased elastic tissue defect formation in the growth restricted brown Norway rat: a potential link between in utero condition and cardiovascular disease. Pediatr Res 2008, 64:125-130.
42. Davies D.P., Platts P., Pritchard J.M., et al. Nutritional status of light-for-date infants at birth and its influence on early postnatal growth. Arch Dis Childhood 1979, 54:703-706.
43. Ong K.K.L., Ahmed M.L., Emmett P.M., et al. Association between postnatal catchup growth and obesity in childhood: prospective cohort study. BMJ 2000, 320:967. the Avon Longitudinal Study of Pregnancy and Childhood Study Team.
44. Fewtrell M.S., Morley R., Abbott R.A., et al. Catch-up growth in small-for-gestational-age term infants: a randomized trial. Am J Clin Nutr 2001, 74:516-523.
45. Kajimura S., Aida K., Duan C. Insulin-like growth factor-binding protein-1 (igfbp-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci U S A 2005, 102:1240-1245.
46. Dy J., Guan H., Sampath-Kumar R., et al. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 2008, 29:193-200.
47. MacLennan N.K., James S.J., Melnyk S., et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004, 18:43-50.
48. Kiserud T., Ebbing C., Kessler J., et al. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol 2006, 28:126-136.
49. Bellotti M., Pennati G., De Gasperi C., et al. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004, 190:1347-1358.
50. Baschat A.A. The fetal circulation and essential organs - a new twist to an old tale. Ultrasound Obstet Gynecol 2006, 27:349-353.
51. Hernandez-Andrade E., Figueroa-Diesel H., Jansson T., et al. Changes in regional fetal cerebral blood flow perfusion in relation to hemodynamic deterioration in severely growth-restricted fetuses. Ultrasound Obstet Gynecol 2008, 32:71-76.
52. Cheung C.Y., Bogic L., Gagnon R., et al. Morphologic alterations in ovine placenta and fetal liver following induced severe placental insufficiency. J Soc Gynecol Invest 2004, 11:521-528.
53. Ream M., Ray A.M., Chandra R., et al. Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 2008, 295:R583-R595.
54. Hemmings D.G., Williams S.J., Davidge S.T. Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am J Physiol Heart Circ Physiol 2005, 289:H674-H682.
55. Baserga M.C., Sola A. Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants. J Perinatol 2004, 24:476-481.
56. Baschat A.A., Cosmi E., Bilardo C.M., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007, 109:253-261.
57. Breeze A.C., Lees C.C. Prediction and perinatal outcomes of fetal growth restriction. Semin Fetal Neonatal Med 2007, 12:383-397.
58. Thornton J.G., Hornbuckle J., Vail A., Spiegelhalter D.J., Levene M. Infant wellbeing at 2 years of age in the growth restriction intervention trial (grit): multicentered randomised controlled trial. Lancet 2004, 364:513-520.
59. Shankaran S., Das A., Bauer C.R., et al. Fetal origin of childhood disease: intrauterine growth restriction in term infants and risk for hypertension at 6 years of age. Arch Pediatr Adolesc Med 2006, 160:977-981.
60. Meyer U., Nyffeler M., Engler A., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
61. Jacobsson B., Ahlin K., Francis A., et al. Cerebral palsy and restricted growth status at birth: population-based case-control study. Br J Obstet Gynaecol 2008, 115:1250-1255.
62. Blair E., Stanley F. Intrauterine growth and spastic cerebral palsy. Association with birth weight for gestational age. Am J Obstet Gynecol 1990, 162:229-237.
63. Topp M., Langhoff-Roos J., Uldall P., et al. Intrauterine growth and gestational age in preterm infants with cerebral palsy. Early Hum Dev 1996, 44:27-36.
64. Walker D.M., Marlow N. Neurocognitive outcome following fetal growth restriction. Arch Dis Child Fetal Neonatal Ed 2008, 93:F322-F325.
65. Leitner Y., Fattal-Valevski A., Geva R., et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol 2007, 22:580-587.
66. Leitner Y., Fattal-Valevski A., Geva R., et al. Six-year follow-up of children with intrauterine growth retardation: long-term, prospective study. J Child Neurol 2000, 15:781-786.
67. Geva R., Eshel R., Leitner Y., et al. Neuropsychological outcome of children with intrauterine growth restriction: a 9-year prospective study. Pediatrics 2006, 118:91-100.
68. O'Keeffe M.J., O'Callaghan M., Williams G.M., et al. Learning, cognitive and attentional problems in adolescents born small for gestational age. Pediatrics 2003, 112:301-307.
69. Karagianni P., Kyriakidou M., Mitsiakos G., et al. Neurological outcome in preterm small for gestational age infants compared to appropriate for gestational age preterm at the age of 18 months: a prospective study. J Child Neurol 2010, 25:165-170.
70. Jelliffe-Pawlowski L.L., Hansen R.L., et al. Neurodevelopmental outcome at 8 months and 4 years among infants born full-term small-for-gestational-age. J Perinatol 2004, 24:505-514.
71. Tideman E., Marsal K., Ley D. Cognitive function in young adults following intrauterine growth restriction with abnormal fetal aortic blood flow. Ultrasound Obstet Gynecol 2007, 29:614-618.
72. Schreuder A.M., McDonnell M., Gaffney G., et al. Outcome at school age following antenatal detection of absent or reversed end diastolic flow velocity in the umbilical artery. Arch Dis Child Fetal Neonatal Ed 2002, 86:F108-F114.
73. Baschat A.A., Viscardi R.M., Hussey-Gardner B., et al. Infant neurodevelopment following fetal growth restriction: relationship with antepartum surveillance parameters. Ultrasound Obstet Gynecol 2009, 33:44-50.
74. Jackson J.A., Wailoo M.P., Thompson J.R., et al. Early physiological development of infants with intrauterine growth retardation. Arch Dis Child Fetal Neonatal Ed 2004, 89:F46-F50.
75. Brodszki J., Lanne T., Marsal K., et al. Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation 2005, 111:2623-2628.
76. Koklu E., Ozturk M.A., Gunes T., et al. Is increased intima-media thickness associated with preatherosclerotic changes in intrauterine growth restricted newborns?. Acta Paediatr 2007, 96:1858. author reply 1859.
77. Pesonen E., Johnsson J., Berg A. Intimal thickness of the coronary arteries in low-birthweight infants. Acta Paediatr 2006, 95:1234-1238.
78. Koklu E., Kurtoglu S., Akcakus M., et al. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res 2006, 65:269-275.
79. Koklu E., Ozturk M.A., Kurtoglu S., et al. Aortic intima-media thickness, serum IGF-i, IGFBP-3, and leptin levels in intrauterine growth-restricted newborns of healthy mothers. Pediatr Res 2007, 62:704-709.
80. Das U.N. A perinatal strategy to prevent coronary heart disease. Nutrition 2003, 19:1022-1027.
81. Burkhardt T., Matter C.M., Lohmann C., et al. Decreased umbilical artery compliance and IGF-i plasma levels in infants with intrauterine growth restriction - implications for fetal programming of hypertension. Placenta 2009, 30:136-141.
82. Bassan H., Trejo L.L., Kariv N., et al. Experimental intrauterine growth retardation alters renal development. Pediatr Nephrol 2000, 15:192-195.
83. Ojeda N.B., Grigore D., Alexander B.T. Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 2008, 15:101-106.
84. Schreuder M.F., Nyengaard J.R., Fodor M., et al. Glomerular number and function are influenced by spontaneous and induced low birth weight in rats. J Am Soc Nephrol 2005, 16:2913-2919.
85. Verburg B.O., Geelhoed J.J.M., Steegers E.A.P., et al. Fetal kidney volume and its association with growth and blood flow in fetal life: the generation R study. Int Soc Nephrol 2007, 72:754-761.
86. Rakow A., Johansson S., Legnevall L., et al. Renal volume and function in school-age children born preterm or small for gestational age. Pediatr Nephrol 2008, 23:1309-1315.
87. Gray I.P., Cooper P.A., Cory B.J., et al. The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity. J Clin Endocrinol Metab 2002, 87:4252-4256.
88. Veening M.A., Van Weissenbruch M.M., Delemarre-Van De Waal H.A. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 2002, 87:5.
89. Neitzke U., Harder T., Schellong K., et al. Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta 2008, 29:246-254.
90. Breant B., Gesina E., Blondeau B. Nutrition, glucocorticoids and pancreas development. Horm Res 2006, 65(Suppl. 3):98-104.
91. Schwitzgebel V.M., Somm E., Klee P. Modeling intrauterine growth retardation in rodents: impact on pancreas development and glucose homeostasis. Mol Cell Endocrinol 2009, 304:78-83.
92. Park J.H., Stoffers D.A., Nicholls R.D., et al. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of pdx1. J Clin Invest 2008, 118:2316-2324.
93. Nusken K.D., Dotsch J., Rauh M., et al. Uteroplacental insufficiency after bilateral uterine artery ligation in the rat: impact on postnatal glucose and lipid metabolism and evidence for metabolic programming of the offspring by sham operation. Endocrinology 2008, 149:1056-1063.
94. Briana D.D., Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol 2009, 160:337-347.
95. Maiorana A., Del Bianco C., Cianfarani S. Adipose tissue: a metabolic regulator. Potential implications for the metabolic outcome of subjects born small for gestational age (sga). Rev Diabet Stud 2007, 4:134-146.
96. Stocker C.J., Arch J.R., Cawthorne M.A. Fetal origins of insulin resistance and obesity. Proc Nutr Soc 2005, 64:143-151.
97. Pylipow M., Spector L.G., Puumala S.E., et al. Early postnatal weight gain, intellectual performance, and body mass index at 7 years of age in term infants with intrauterine growth restriction. J Pediatr 2009, 154:201-206.
98. Chakraborty S., Joseph D.V., Bankart M.J., et al. Fetal growth restriction: relation to growth and obesity at the age of 9 years. Arch Dis Child Fetal Neonatal Ed 2007, 92:F479-F483.
99. Mitchell E.A., Robinson E., Clark P.M., et al. Maternal nutritional risk factors for small for gestational age babies in a developed country: a case-control study. Arch Dis Child Fetal Neonatal Ed 2004, 89:F431-F435.
100. Kwon H., Ford S.P., Bazer F.W., et al. Maternal nutrient restriction reduces concentrations of amino acids and polyamines in ovine maternal and fetal plasma and fetal fluids. Biol Reprod 2004, 71:901-908.
101. Grazuleviciene R., Danileviciute A., Nadisauskiene R., et al. Maternal smoking, gstm1 and gstt1 polymorphism and susceptibility to adverse pregnancy outcomes. Int J Environ Res Public Health 2009, 6:1282-1297.
102. Lopez N.B., Choonara I. Can we reduce the number of low-birth-weight babies? The Cuban experience. Neonatology 2009, 95:193-197.
103. Picconi J.L., Kruger M., Mari G. Ductus venosus s-wave/isovolumetric a-wave (SIA) index and a-wave reversed flow in severely premature growth-restricted fetuses. J Ultrasound Med 2008, 27:1283-1289.
104. Halliday H.L. Neonatal management and long-term sequelae. Best Pract Res Clin Obstet Gynaecol 2009, 23:871-880.
105. Yeung M.Y. Postnatal growth, neurodevelopment and altered adiposity after preterm birth-from a clinical nutrition perspective. Acta Paediatr 2006, 95:909-917.
106. Attig L., Djiane J., Gertler A., et al. Study of hypothalamic leptin receptor expression in low-birth-weight piglets and effects of leptin supplementation on neonatal growth and development. Am J Physiol Endocrinol Metab 2008, 295:E1117-E1125.
107. Edouard T., Trivin C., Lawson-Body E., et al. Extreme short stature after intrauterine growth retardation: factors associated with lack of catch-up growth. Horm Res 2004, 61:33-40.
108. Delemarre E.M., Rotteveel J., Delemarre-van de Waal H.A. Metabolic implications of growth hormone treatment in small for gestational age. Eur J Endocrinol 2007, 157(Suppl. 1):S47-S50.
109. Dunger D.B., Ong K.K. Endocrine and metabolic consequences of intrauterine growth retardation. Endocrinol Metab Clin North Am 2005, 34:597-615.
110. Huber K., Miles J.L., Norman A.M., et al. Prenatally-induced changes in muscle structure and metabolic function facilitate exercise-induced obesity prevention. Endocrinology 2009, 150:4135-4144.
111. Miles J.L., Huber K., Thompson N.M., et al. Moderate daily exercise activates metabolic flexibility to prevent prenatally induced obesity. Endocrinology 2009, 150:179-186.
112. Saenger P., Czernichow P., Hughes I., et al. Small for gestational age: short stature and beyond. Endocr Rev 2007, 28:219-251.